|
Fusion gene ID: 29825 |
FusionGeneSummary for QTRT1_IRF2BP2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: QTRT1_IRF2BP2 | Fusion gene ID: 29825 | Hgene | Tgene | Gene symbol | QTRT1 | IRF2BP2 | Gene ID | 81890 | 359948 |
Gene name | queuine tRNA-ribosyltransferase catalytic subunit 1 | interferon regulatory factor 2 binding protein 2 | |
Synonyms | FP3235|TGT|TGUT | CVID14 | |
Cytomap | 19p13.2 | 1q42.3 | |
Type of gene | protein-coding | protein-coding | |
Description | queuine tRNA-ribosyltransferase catalytic subunit 1TGT, 43-KD subunitTGT, catalytic subunitguanine insertion enzymequeuine tRNA-ribosyltransferase 1tRNA-guanine transglycosylase | interferon regulatory factor 2-binding protein 2IRF-2-binding protein 2 | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q9BXR0 | Q7Z5L9 | |
Ensembl transtripts involved in fusion gene | ENST00000250237, ENST00000585885, | ENST00000366610, ENST00000366609, ENST00000491430, | |
Fusion gene scores | * DoF score | 2 X 3 X 2=12 | 4 X 4 X 2=32 |
# samples | 3 | 4 | |
** MAII score | log2(3/12*10)=1.32192809488736 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: QTRT1 [Title/Abstract] AND IRF2BP2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | QTRT1 | GO:0101030 | tRNA-guanine transglycosylation | 20354154 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | AI919001 | QTRT1 | chr19 | 10823892 | - | IRF2BP2 | chr1 | 234743504 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000250237 | ENST00000366610 | QTRT1 | chr19 | 10823892 | - | IRF2BP2 | chr1 | 234743504 | + |
In-frame | ENST00000250237 | ENST00000366609 | QTRT1 | chr19 | 10823892 | - | IRF2BP2 | chr1 | 234743504 | + |
5CDS-5UTR | ENST00000250237 | ENST00000491430 | QTRT1 | chr19 | 10823892 | - | IRF2BP2 | chr1 | 234743504 | + |
intron-3CDS | ENST00000585885 | ENST00000366610 | QTRT1 | chr19 | 10823892 | - | IRF2BP2 | chr1 | 234743504 | + |
intron-3CDS | ENST00000585885 | ENST00000366609 | QTRT1 | chr19 | 10823892 | - | IRF2BP2 | chr1 | 234743504 | + |
intron-5UTR | ENST00000585885 | ENST00000491430 | QTRT1 | chr19 | 10823892 | - | IRF2BP2 | chr1 | 234743504 | + |
Top |
FusionProtFeatures for QTRT1_IRF2BP2 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
QTRT1 | IRF2BP2 |
Catalytic subunit of the queuine tRNA-ribosyltransferase(TGT) that catalyzes the base-exchange of a guanine (G) residuewith queuine (Q) at position 34 (anticodon wobble position) intRNAs with GU(N) anticodons (tRNA-Asp, -Asn, -His and -Tyr),resulting in the hypermodified nucleoside queuosine (7-(((4,5-cis-dihydroxy-2-cyclopenten-1-yl)amino)methyl)-7-deazaguanosine)(PubMed:11255023, PubMed:20354154). Catalysis occurs through adouble-displacement mechanism. The nucleophile active site attacksthe C1' of nucleotide 34 to detach the guanine base from the RNA,forming a covalent enzyme-RNA intermediate. The proton acceptoractive site deprotonates the incoming queuine, allowing anucleophilic attack on the C1' of the ribose to form the product(By similarity). {ECO:0000250|UniProtKB:P28720, ECO:0000255|HAMAP-Rule:MF_03218, ECO:0000269|PubMed:11255023,ECO:0000269|PubMed:20354154}. | Acts as a transcriptional corepressor in a IRF2-dependent manner; this repression is not mediated by histonedeacetylase activities. Represses the NFAT1-dependenttransactivation of NFAT-responsive promoters. Acts as acoactivator of VEGFA expression in cardiac and skeletal muscle.{ECO:0000269|PubMed:12799427, ECO:0000269|PubMed:20702774,ECO:0000269|PubMed:21576369}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for QTRT1_IRF2BP2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_QTRT1_ENST00000250237_chr19_10823892_-_IRF2BP2_ENST00000366610_chr1_234743504_+_0aa >In-frame_QTRT1_ENST00000250237_chr19_10823892_-_IRF2BP2_ENST00000366609_chr1_234743504_+_0aa |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_QTRT1_ENST00000250237_chr19_10823892_-_IRF2BP2_ENST00000366610_chr1_234743504_+_0nt >In-frame_QTRT1_ENST00000250237_chr19_10823892_-_IRF2BP2_ENST00000366609_chr1_234743504_+_0nt |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_QTRT1_ENST00000250237_chr19_10823892_-_IRF2BP2_ENST00000366610_chr1_234743504_+_0nt >In-frame_QTRT1_ENST00000250237_chr19_10823892_-_IRF2BP2_ENST00000366609_chr1_234743504_+_0nt |
Top |
FusionGenePPI for QTRT1_IRF2BP2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for QTRT1_IRF2BP2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for QTRT1_IRF2BP2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | IRF2BP2 | C0023487 | Acute Promyelocytic Leukemia | 1 | CTD_human |